CCL2 produced by CD68+/CD163+ macrophages as a promising clinical biomarker of microscopic polyangiitis-interstitial lung disease.
Rheumatology (Oxford). 2021 Oct 2;60(10):4643-4653. doi: 10.1093/rheumatology/keab064.
Rheumatology (Oxford). 2021.
PMID: 33493350